These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16175356)

  • 1. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study.
    Mego M; Koncekova R; Mikuskova E; Drgona L; Ebringer L; Demitrovicova L; Nemova I; Trupl J; Mardiak J; Koza I; Zajac V
    Support Care Cancer; 2006 Mar; 14(3):285-90. PubMed ID: 16175356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.
    Mego M; Ebringer L; Drgona L; Mardiak J; Trupl J; Greksak R; Nemova I; Oravcova E; Zajac V; Koza I
    Neoplasma; 2005; 52(2):159-64. PubMed ID: 15800715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
    Lalami Y; Paesmans M; Aoun M; Munoz-Bermeo R; Reuss K; Cherifi S; Alexopoulos CG; Klastersky J
    Support Care Cancer; 2004 Oct; 12(10):725-30. PubMed ID: 15235901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
    Tamai Y; Imataki O; Kawakami K
    Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for prevention of febrile neutropenia].
    Barroso S; Damasceno M; Dinis J; Gervásio H; da Luz R; Passos-Coelho JL; Sá A; Costa L; Rodrigues H; Andrade S; Macedo A; Moital I
    Acta Med Port; 2008; 21(1):7-19. PubMed ID: 18489831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of granulocyte colony stimulating factor as a secondary prophylaxis along with full-dose chemotherapy following a prior cycle of febrile neutropenia.
    Gupta S; Singh PK; Bhatt ML; Pant MC; Gupta R; Negi MP
    Biosci Trends; 2010 Oct; 4(5):273-8. PubMed ID: 21068482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the probiotic Enterococcus faecium NCIMB 10415 on selected lactic acid bacteria and enterobacteria in co-culture.
    Starke IC; Zentek J; Vahjen W
    Benef Microbes; 2015; 6(3):345-52. PubMed ID: 25519527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies.
    Moreau M; Klastersky J; Schwarzbold A; Muanza F; Georgala A; Aoun M; Loizidou A; Barette M; Costantini S; Delmelle M; Dubreucq L; Vekemans M; Ferrant A; Bron D; Paesmans M
    Ann Oncol; 2009 Mar; 20(3):513-9. PubMed ID: 19139177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
    Blay JY; Chauvin F; Le Cesne A; Anglaret B; Bouhour D; Lasset C; Freyer G; Philip T; Biron P
    J Clin Oncol; 1996 Feb; 14(2):636-43. PubMed ID: 8636781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials.
    Pinto L; Liu Z; Doan Q; Bernal M; Dubois R; Lyman G
    Curr Med Res Opin; 2007 Sep; 23(9):2283-95. PubMed ID: 17697451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
    Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.
    Vogel CL; Wojtukiewicz MZ; Carroll RR; Tjulandin SA; Barajas-Figueroa LJ; Wiens BL; Neumann TA; Schwartzberg LS
    J Clin Oncol; 2005 Feb; 23(6):1178-84. PubMed ID: 15718314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
    Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
    Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy.
    Mądry R; Popławska L; Haslbauer F; Šafanda M; Ghizdavescu D; Benkovicova J; Csőszi T; Mihaylov G; Niepel D; Jaeger C; Frkanova I; Macovei A; Staudigl C
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):238-47. PubMed ID: 26745973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
    Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.
    Jolis L; Carabantes F; Pernas S; Cantos B; López A; Torres P; Funes C; Caballero D; Benedit P; Salar A;
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):513-21. PubMed ID: 23730920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
    Sugahara H; Mizuki M; Matsumae S; Nabetani Y; Kikuchi M; Kanakura Y
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):51-4. PubMed ID: 14756220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A general description of the clinical guideline for the management of febrile neutropenia].
    Takamatsu Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):697-702. PubMed ID: 23863646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer.
    Cousin S; Le Rhun E; Mailliez A; Fournier C; Bonneterre J
    Bull Cancer; 2012; 99(7-8):75-80. PubMed ID: 22713627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.